The Effect of Isoflavone Supplement on Plasma Lipids & Antioxidant Status in Hypercholesterolemic Postmenopausal Women

고지혈증인 폐경 후 여성에서 이소플라본 보충이 혈청 지질 농도 및 항산화능에 미치는 영향

  • Lee, Jong-Ho (Department of Food and Nutrition, Yonsei University) ;
  • Kim, Eun-Mi (Department of Dietetic, Kangbuk Samsung Hospital) ;
  • Chae, Ji-Sook (Department of Food and Nutrition, Yonsei University) ;
  • Jang, Yang-Soo (Department of Cardiology, College of Medicien, Yonsei University) ;
  • Lee, Jin-Hee (Nutraceuticals & Functional Foods Division, CJ Foods R&D, CJ Corp.) ;
  • Lee, Geun (Nutraceuticals & Functional Foods Division, CJ Foods R&D, CJ Corp.)
  • 이종호 (연세대학교 식품영양학과) ;
  • 김은미 (강북삼성병원 영양실) ;
  • 채지숙 (연세대학교 식품영양학과) ;
  • 장양수 (연세대학교 의과대학 심장내과학교실) ;
  • 이진희 (CJ(주) 식품연구소) ;
  • 이근 (CJ(주) 식품연구소)
  • Published : 2003.07.01

Abstract

Postmenopausal women are at an increased risk of developing coronary artery disease. This is due to primarily dyslipidemia accompanying the loss of estrogen secretion. Soy isoflavones are known to have weak estrogenic effects. The purpose of this study is to investigate whether isoflavone supplement improves the risk of cardiovascular disease in hypercholesterolemic postmenopausal women. Subjects consisted of 39 Korean postmenopausal women with hypercholesterolemia (total cholesterol $\geq$ 200 mg/㎗ or LDL cholesterol $\geq$ 130 mg/㎗). Subjects were divided into 2 groups; placebo group (PG), isoflavone supplement group (IG). During 12 weeks, subjects were given placebo and 80mg isoflavone daily. Anthropometric measurement, blood sample analysis and dietary intake measurement were taken at baseline and after 12 weeks. After 12 weeks, systolic blood pressure was decreased significantly (p < 0.01) and plasma HDL cholesterol level was increased significantly (p < 0.05) in IG. But there were no significant changes in plasma total cholesterol, LDL cholesterol and triglyceride levels after isoflavone supplementation. There was a negative correlation between initial plasma HDL cholesterol level and the extent of plasma HDL cholesterol reduction in IG (r=-0.572, p=0.012). Atherogenic index (AI), total-/LDL- cholesterol ratio and LDL/HDL cholesterol ratio were improved significantly after isoflavone supplementation. In subjects whose initial plasma LDL cholesterol level were above 160 mg/㎗, plasma malondialdehyde (MDA) level were decreased and total antioxidant status (TAS) were increased significantly after isoflavone supplement (p < 0.05). However there were no significant changes in flow-mediated dilator (FMD), the marker of endothelium-dependent vasodilation and nitroglycerine-mediated dilator (NMD), the marker of endothelium-independent vasodilation and the extent of DNA damage after isoflavone supplement. In conclusion, these results indicate that isoflavone supplement may decrease the risk of cardiovascular disease via improving blood pressure, HDL cholesterol level and AI in hypercholesterolemic postmenopausal women. Futhermore, in case of subjects with elevated LDL cholesterol level, isoflavone supplementation may have more antiatherogenic effects via improving antioxidant status.

Keywords

References

  1. Lancet v.347 Age at menopause as a risk factor for cardiovascular mortality van der Schouw YT;van der Graaf Y;Steyerberg,E.W.;Eijkemans,J.C.;Bangs,J.D. https://doi.org/10.1016/S0140-6736(96)90075-6
  2. J Clin Epidemiol v.53 no.5 Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis: The Tromso Study Joakimsen,O.;Bonaa,K.H.;Stensland-bigge,E.;Jacksen,B.K. https://doi.org/10.1016/S0895-4356(99)00197-3
  3. Atherosclerosis v.147 The effect of menopause on blood lipid and lipoprotein levels De Aloysio D.;Gambaccian,M.;Mescha,M.;Pansini,F.;Modena,A.B.;Bols,P.F.;Massobrio,M.;Maioxchi,G.;Peruzzi,E. https://doi.org/10.1016/S0021-9150(99)00315-9
  4. J Epidemiol v.19 Menopause-related change s in lipoproteins and some other cardiovascular risk factors.Int Bonithon-Kopp,C.;Scarabin,P.Y.;Darne,B.;Malmejac,A.;Guizz,I. https://doi.org/10.1093/ije/19.1.42
  5. Pastgrad Med v.111 Estrogens and lipids. Can HRT designer estrogens and phytoestrogens reduce cardiovascular risk marker after menopause Ariyo,Villablancs A.C.
  6. N Engl J Med v.332 Cholesterol reduction in cardiovascular disease: Clinical benefits and possible mechanisms Levine,G.N.;Keaney,J.F.Jr.;Vita,J.A. https://doi.org/10.1056/NEJM199502233320807
  7. Am Heart J v.131 Atherosclerosis: Risk factors and the vascular endothelium Glasser,S.P.;Selwyn,A.P.;Ganz,P. https://doi.org/10.1016/S0002-8703(96)90370-1
  8. Clin Cardiol v.20 Coronary risk factors, endothelial function, and atherosclerosis: A review Vogel,R.A. https://doi.org/10.1002/clc.4960200505
  9. J Am Coll Cardiol v.35 Phytoestrogens and cardiovascular health Lissin.L.W.;Cooke,J.P. https://doi.org/10.1016/S0735-1097(00)00590-8
  10. J Nutr v.125 Soy and cholesterol reduction Clinical experience Sirtori,C.R.;Lovatu,M.R.;Manzoni,C.;Moneth,M.;Puzzucconi,F.;Gatti,E.
  11. J Nutr v.125 Overview of proposed mechanisms for the hypocholesterolemic effect of soy Potter,S.M.
  12. Biochem Pharmacol v.60 Dietary soy-derived isoflavone phytoestrogens: Could they have a role in coronary heart disease prevention Tikkamen,M.J.;Adlercreutz,H. https://doi.org/10.1016/S0006-2952(99)00409-8
  13. J Nutr v.132 Soy, soy phytoestrogens and cardiovascular disease Clarkson,T.B.
  14. Am J Clin Nutr v.73 The effect of soy protein with or without isoflavone felative to milk protein on plasma lipids in hypercholesterolemic postmenopusal women Gardner,C.D.;Newell,K.A.;Cherin,R.;Haskell,W.L.
  15. J Am Coll Nutr v.21 Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: A four week study Uesugi,T.;Fukui,Y.;Yamori,Y. https://doi.org/10.1080/07315724.2002.10719200
  16. Clin Chem v.18 Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultraecentrifuge Friedewald,W.T.;Levy,R.I.;Fredicson,D.S.
  17. J Nutr v.115 Effect of dietary polyunsaturated/saturated fatty acid ratio and dietary vitamin E on lipid peroxidation in the rat Buckingham,K.W.
  18. J Chromatogr B Biomed Appl v.667 Analysis of F2 isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry development of a solid phase extraction procedure Nourooze-Zadeh,J.;Copaul,N.K.;Barrow,S.;Mallet,A.L.;Anggard,E.E. https://doi.org/10.1016/0378-4347(95)00035-H
  19. Free Radic Biol Med v.27 In vivi total antioxidant capacity:Comparision of different analitical methods Ronald,L.;Prior,C.;Gouhua,C. https://doi.org/10.1016/S0891-5849(99)00203-8
  20. Exp Cell Res v.175 A simple technique for quantitation of low levels of DNA damage in individual cells Singh,P.N.;McCoy,M.T.;Tice,R.R.;Schneider,E.L. https://doi.org/10.1016/0014-4827(88)90265-0
  21. Diagnosis and treatment of obesity-Guideline for Asia·Pacific Korean Society for the Study of Obesity
  22. Am J Physiol Regul Integr Comp Physiol v.281 Dietary soy exerts an antypertensive effect in spontaneously hypertensive female rats Martin,D.S.;Breitkopf,N.P.;Eyster,K.M.;Williams,J.L.
  23. J Agric Food Chem v.49 Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats Wu,J.;Ding,X. https://doi.org/10.1021/jf000695n
  24. Menopause v.6 Effect of soy protein supplementation on serum lipoprotein, blood pressure, and menopausal symptom in primenopausal women Washburns,S.;Burke,G.L.;Morgan,T.;Anthony,M.
  25. J Clin Endocrinal Metab v.86 Dietary soy has both beneficial and potentially adverse cardiovascular effects: A placebo-controlled study in men and postmenopausal women Teede,H.J.;Dalais,F.S.;Kotsopoulos,D.;Liang,U.L.;David,S.;Mcgrath,B.P. https://doi.org/10.1210/jc.86.7.3053
  26. Atherosclerosis v.145 Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high normal blood pressure Hodgson,J.M.;Puddey,J.B.;Croft,K.D.;Mori,T.A.;Rivera,J.;Beilin,L.J. https://doi.org/10.1016/S0021-9150(99)00029-5
  27. Am J Clin Nutr v.68 Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, post menopausal women Baum,J.A.;Teng,H.;Erdman,J.W.Jr.;Weight,R.M.;Klein,B.P.;Persky,V.W.;Freels,S.;Surya,P.;Bakhit,R.M.;Romos,E.;Shay,N.F.;Potter,S.M.
  28. JAMA v.285 Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults;Summary of the third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults https://doi.org/10.1001/jama.285.19.2486
  29. Clin Exp Pharmacol Physiol v.27 The effect of isoflavone supplementation on serum lipids in post menopausal women Owen,A.;Baughurst,P.
  30. Kor J Nutr v.34 Dose response relationship of isofalvone supplementation on plasma lipid profiles and total antioxidants status in perimenopausal and postmenopausal women Choi,Y.;Yoon,S.;Lee,M.J.;Lee,S.K.;Lee,B.S.
  31. Arteriosclerosis, Thrombosis Vascular Biol v.17 Soy isofalvones improve systemic compiance but not plasma lipids in menopausal and preimenopausal women Nestel,P.Y.;Yamasbita,T.;Sasahara,T.;Pomeroy,S.;Diat,A.;Komesaroff,P.;Owen,A.;Abbey,M. https://doi.org/10.1161/01.ATV.17.12.3392
  32. J Clin Endocrinol Metab v.84 Isofalvones from red clover improve systemic arterial compliance but not plasma lipids in menopusal women Nestel,P.J.;Pomeroy,S.;Kay,S.;Komesaroff,P.;Behresing,J.;Cameron,J.D.;West,L. https://doi.org/10.1210/jc.84.3.895
  33. Atherosclerosis v.147 The effect of supplementation with isoflavone on plasma lipids and oxidisability of low density lipoprotein in premenopausal Samman,S.;Wall,P.M.L.;Chan,G.S.M.;Smith,S.J.;Petocz,P. https://doi.org/10.1016/S0021-9150(99)00196-3
  34. J Clin Endocrinol Metab v.87 The effects of soy-derived phytoestrogen on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women Dewell,A.;Hollenbeck,C.B.;Barace,B. https://doi.org/10.1210/jc.87.1.118
  35. Atherosclerosis v.152 The effect of dietary supplementation with isoflaveones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolemia Howen,J.B.;Sullivan,D.;Lai,N.;Nestel,P.;Pomeroy,S.;West,L.;Eden,J.A.;Howes,L.G. https://doi.org/10.1016/S0021-9150(99)00437-2
  36. N Engl J Med v.333 Meta analysis of the effect of soy protein intake on serum lipids Anderson,J.W.;Johnstone,B.M.;Cook-newell,M.E. https://doi.org/10.1056/NEJM199508033330502
  37. Clin Invest Med v.20 Effects of subsituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia Kurowska,E.M.;Jordan,J.;Spence,J.D.;Wetmone,S.;Piche,L.A.;Radzikowski,M.;Dandona,P.;Carroll,K.K.
  38. J Biol Chem v.262 Binding of high density lipoprotein to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface Slotte,J.P.;Oran,J.F.;Bierman,E.L.
  39. Am J Epidemiol v.131 High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study Jacobs,D.R.Jr.;Mebene,I.L.;Bangdiwala,S.I.;Criqui,M.H.;Tylor,H.A.
  40. Am J Obstet Gynecol v.158 Cardiovascular disease in women Castelli,W.P.
  41. Circulation v.79 High density lipoprotein cholesterol and cardiovascular disease;Four prospective American studies Godon,D.J.;Probstifield,J.L.;Garrison,R.J.;Castelli,W.P.;Knoke,J.D.;Jacobs,D.R.Jr.;Bandwala,S.;Tyroler,H.A. https://doi.org/10.1161/01.CIR.79.1.8
  42. Clin Physiol v.18 Methodological aspects of the evaluation of endothelium dependent vasodiliatation in the human forearm Lind,L.;Sarabi,M.;Millgard,J. https://doi.org/10.1046/j.1365-2281.1998.00077.x
  43. Cancer Epidemiol Biomakers Prev v.5 Stimulatory influence of soy protein isolate on breast secretion in pre and post menopausal women Petrakis,N.L.;Barnes,S.;King,E.B.
  44. Am J Clin Nutr v.72 Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans Wiseman,H.;O'Relly,J.D.;Adlecreutz,H.;Mallet,A.L.;Bowey,E.A.;Rowland,I.R.;Sanders,T.A.B.
  45. Pro Natl Acad Sci USA v.95 Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance Tikkanen,M.I.;Wahala,K.;Ojala,S.;Vihma,V.;Adlercreutz,H. https://doi.org/10.1073/pnas.95.6.3106
  46. Nutr Res v.22 Soy protein antioxidant actions in active, young adults women Bazzoli,D.L.;Hill,S.;di Silvestro,R. https://doi.org/10.1016/S0271-5317(02)00397-4
  47. Mutation Res v.485 Effect of phytoestrogen and antioxidant supplementation on oxidative damage assessed using the comet assay Sirens,J.;Hardly,J.A.;Campbell,M.J.;Leathem.A.J.C.;Woodside,J.V. https://doi.org/10.1016/S0921-8777(00)00069-0
  48. Am J Cardiol v.82 Effect of conjugated estrogen on peripheral flow mediated vasodilation in post menopausal women Al-Khalili,F.;Eriksson,M.;Landgren,B.M.;Schenck-Gustafsson,K. https://doi.org/10.1016/S0002-9149(98)00314-2
  49. Ann Intern Med v.121 Estrogen improves endothelium dependent flow-mediated vasodilation in post menopausal women Lieverman,E.H.;Gerhard,M.D.;Uehata,A.;Walsh,B.W.;Selwyn,A.P.;Ganz,P.;Yeung,A.C.;Creager,M.A. https://doi.org/10.7326/0003-4819-121-12-199412150-00005
  50. Am J Cardiol v.85 Phytoestrogen do not influence lipoprotein levels or endothelial function in heathy, postmenopausal women Simons,L.A.;von Konigsmark,M.;Simons,J.;Celermajer,D.S. https://doi.org/10.1016/S0002-9149(00)00759-1
  51. N Engl J Med v.334 Passive smoking and impaired endothelium arteial dilatation in healthy young adults Celermajer,D.S.;Adams,M.R.;Clarkson,P.;Robinson,J.;McCredie,R.;Donald,A.;Deanfield,J.E. https://doi.org/10.1056/NEJM199601183340303